lung adenocarcinoma

Showing 26 - 50 of 78

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Radiomics Combined With Frozen Section Prediction Model for

Not yet recruiting
  • Lung Adenocarcinoma
  • radiomics
  • (no location specified)
Jun 22, 2022

Extensive Stage Small Cell Lung Carcinoma, Lung Adenocarcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in Scottsdale,

Recruiting
  • Extensive Stage Small Cell Lung Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +1 more
Jun 27, 2022

Lung Adenocarcinoma, Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United States (biological, procedure,

Recruiting
  • Lung Adenocarcinoma
  • +2 more
  • Ipilimumab
  • +5 more
  • Conroe, Texas
  • +4 more
May 25, 2022

Exhaled Breath Particles in Lung Cancer

Recruiting
  • Lung Cancer
  • +3 more
  • EBPcollected using the PExA device.
  • Lund, Skåne Län, Sweden
    Skåne University Hospital
May 24, 2022

Colorectal Carcinoma, Lung Adenocarcinoma, Malignant Solid Tumor Trial in Buffalo (Binimetinib, Palbociclib, Therapeutic

Recruiting
  • Colorectal Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 11, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY314, Combination Therapy: PY314 +

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • PY314
  • Combination Therapy: PY314 + Pembrolizumab
  • Scottsdale, Arizona
  • +12 more
Mar 28, 2022

Lung Cancer, Pulmonary Rehabilitation, Exercise Trial (pulmonary rehabilitation exercise)

Not yet recruiting
  • Lung Cancer
  • +9 more
  • pulmonary rehabilitation exercise
  • (no location specified)
Mar 6, 2022

Surgery, Lung Adenocarcinoma Trial in Chengdu (Qualitative interviews)

Recruiting
  • Surgery
  • Lung Adenocarcinoma
  • Qualitative interviews
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital & Institute
Feb 22, 2022

Cios Mobile 3D Spin for Robotic Bronchoscopy

Recruiting
  • Pulmonary Nodule, Solitary
  • +4 more
  • Ion Endoluminal System
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 1, 2022

Lung Cancer, Lung Adenocarcinoma, EGFR Activating Mutation Trial in Vandoeuvre-lès-Nancy (Collection of surgical waste)

Enrolling by invitation
  • Lung Cancer
  • +4 more
  • Collection of surgical waste
  • Vandoeuvre-lès-Nancy, Lorraine, France
    Seitlinger
Nov 24, 2021

Lung Adenocarcinoma, Cryotherapy Effect Trial in Bordeaux (Cryoablation, Pembrolizumab, Pemetrexed)

Recruiting
  • Lung Adenocarcinoma
  • Cryotherapy Effect
  • Cryoablation
  • +3 more
  • Bordeaux, Gironde, France
    Institut Bergonié
Oct 29, 2021

Lung Tumors, Lung Cancer, Lung Adenocarcinoma Trial in Singapore (CT scans)

Completed
  • Lung Neoplasms
  • +2 more
  • CT scans
  • Singapore, Singapore
    Singhealth Institutions
Sep 29, 2021

Tumor Spread Through Air Space in Lung Adenocarcinoma

Completed
  • Lung Adenocarcinoma
    • Roma, Italy
      Dipartimento di chirurgia Generale e Specialistica "Paride Stefa
    Sep 3, 2021

    Identify Prognostic Biomarkers of Lung Cancer

    Recruiting
    • Lung Cancer
    • +3 more
      • Shanghai, China
        Renji Hospital, Shanghai Jiaotong University school of medicine
      Aug 14, 2021

      Lung Adenocarcinoma Trial (Furmonertinib)

      Not yet recruiting
      • Lung Adenocarcinoma
      • (no location specified)
      Jul 8, 2021

      Lung Adenocarcinoma Trial in China (Segmentectomy with systemic lymph node dissection, Lobectomy with hilar and mediastinal

      Recruiting
      • Lung Adenocarcinoma
      • Segmentectomy with systemic lymph node dissection
      • Lobectomy with hilar and mediastinal lymph node dissection
      • Changzhou, Jiangsu, China
      • +5 more
      Jun 21, 2021

      Lung Adenocarcinoma Trial in ZhengZhou (CIK, chemo)

      Terminated
      • Lung Adenocarcinoma
      • ZhengZhou, Henan, China
        Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
      May 10, 2021

      Lung Adenocarcinoma, Colon Adenocarcinoma Trial in Boston

      Completed
      • Lung Adenocarcinoma
      • Colon Adenocarcinoma
        • Boston, Massachusetts
        • +1 more
        Feb 8, 2021

        Lung Adenocarcinoma, 18F-FDG, 68Ga-FAPI Trial in Xiamen (68Ga-FAPI PET/CT scan)

        Unknown status
        • Lung Adenocarcinoma
        • +3 more
        • 68Ga-FAPI PET/CT scan
        • Xiamen, Fujian, China
          The First Affiliated Hospital of Xiamen University
        Oct 9, 2020

        Scoring System to Distinguish Cryptococcosis and Adenocarcinoma

        Unknown status
        • Cryptococcosis
        • Lung Adenocarcinoma
        • A scoring system
        • Shanghai, Shanghai, China
          Shanghai pulmonary hospital
        Sep 17, 2020

        Bronchioloalveolar Carcinoma, Large Cell Lung Carcinoma, Lung Adenocarcinoma Trial in Sacramento, Worcester, Bronx (Erlotinib

        Completed
        • Bronchioloalveolar Carcinoma
        • +5 more
        • Erlotinib Hydrochloride
        • +2 more
        • Sacramento, California
        • +4 more
        Aug 28, 2020

        Lung Adenocarcinoma Trial (Jing-yan-kang Granule, PC chemo and symptomatic treatment)

        Unknown status
        • Lung Adenocarcinoma
        • Jing-yan-kang Granule
        • PC chemotherapy and symptomatic treatment
        • (no location specified)
        Jul 18, 2020

        Lung Adenocarcinoma Trial in Zhengzhou (Icotinib, Pemetrexed/Carboplatin)

        Unknown status
        • Lung Adenocarcinoma
        • Zhengzhou, Henan, China
          Henan cancer hospital
        Jun 30, 2020

        Lung Cancer, Lung Diseases, Lung Cancer, Nonsmall Cell Trial in Toronto (Chest Xray, No daily chest xray)

        Completed
        • Lung Cancer
        • +4 more
        • Chest Xray
        • No daily chest xray
        • Toronto, Ontario, Canada
          Toronto General Hospital
        Apr 29, 2020

        Lung Adenocarcinoma, EGFR Activating Mutation Trial (icotinib combined with pemetrexed plus cisplatin, first icotinib and then

        Completed
        • Lung Adenocarcinoma
        • EGFR Activating Mutation
        • icotinib combined with pemetrexed plus cisplatin
        • first icotinib and then pemetrexed plus cisplatin
        • (no location specified)
        Oct 11, 2019